Skip to playerSkip to main content
Pfizer Stock Update 2025: Rebound Coming or More Trouble Ahead? 💊📉
https://newsplusglobe.medium.com/
Pfizer (PFE) stock is under the spotlight again! After a major drop following the post-COVID slowdown, is Pfizer ready for a comeback? We cover its latest moves — from new cancer drugs to its $43B Seagen deal — and what analysts are saying about its future.
📊 Will PFE rebound or continue to decline?
👇 Watch the full update and share your thoughts in the comments!

#Pfizer #PFE #StockMarket #Investing #PharmaStocks #PfizerStock #Seagen #WallStreet #StockNews #Biotech #FinanceNews #HealthStocks #StocksToWatch #PfizerUpdate #PFE2025

Category

🗞
News
Transcript
00:00Pfizer stock PFE is making headlines again, but is it time to buy, sell, or wait?
00:07Pfizer, once a market darling during the vaccine boom, has seen its shares slide over the past
00:13year, dropping more than 30 as COVID-related revenues faded and investor confidence wavered.
00:19But now, Pfizer's betting big on new treatments, from cancer therapies to weight loss drugs,
00:25and a $43 billion CGEN acquisition. Wall Street? Still mixed. Some analysts say there's long-term
00:33upside. Others remain cautious due to weak near-term earnings. Is Pfizer gearing up for
00:39a comeback or facing more uncertainty? Let us know your take. Will PFE rebound or keep sinking?
Be the first to comment
Add your comment

Recommended